Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial.

Karim FizaziMargitta RetzDaniel P PetrylakJeffrey C GohJose Perez-GraciaLouis LacombeStefanie ZschäbitzMauricio BurottoHakim MahammediGwenaelle GravisDiogo Assed BastosSteven L McCuneJuan Carlos Vázquez LimónEdmond M KwanDaniel CastellanoAude FléchonFred SaadMarc-Oliver GrimmDavid R ShafferAndrew J ArmstrongPrabhu BhagavatheeswaranNeha P AminKeziban Ünsal-KaçmazXuya WangJun LiAndrea LoehrRussell K Pachynski

Published in: Journal for immunotherapy of cancer (2022)

NCT03338790.

Keyphrases

squamous cell carcinoma
phase iii
study protocol
small cell lung cancer
phase ii
clinical trial
randomized controlled trial
open label